Fever, a common symptom in clinical practice, often presents a diagnostic challenge due to its nonspecific nature. Understanding the comprehensive approach to fever can help clinicians effectively manage this common symptom and identify potential underlying conditions.
Fever is a physiological response to a variety of conditions, most commonly infections. However, it can also be a manifestation of non-infectious diseases such as malignancies, autoimmune disorders, and drug reactions. Understanding the etiology is crucial in guiding the diagnostic workup and management plan.
A thorough history and physical examination remain the cornerstone of the diagnostic process. Key elements include the duration and pattern of fever, associated symptoms, travel history, exposure to infectious diseases, and drug history. The physical examination should be comprehensive, focusing on potential sources of infection or signs of systemic diseases.
Investigations should be guided by the clinical assessment. Basic investigations include complete blood count, blood cultures, urine analysis, and chest radiography. Further investigations like serological tests, imaging studies, or tissue biopsies may be needed based on the suspected underlying condition.
Management of fever involves treating the underlying cause and symptomatic relief. Empirical antibiotics may be started in patients with suspected bacterial infections while awaiting culture results. Non-infectious causes require specific treatments based on the diagnosed condition.
A comprehensive approach to fever in clinical practice involves a systematic evaluation of the patient's history, physical examination, and appropriate investigations. This approach aids in identifying the underlying cause and implementing an effective management plan, thereby improving patient outcomes.
1.
Regular physical activity before cancer diagnosis may lower progression and death risks
2.
Medication Self-Injection Embraced by Breast Cancer Patients
3.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
4.
FDA Advisors Split on Regimens for Breast, Prostate Cancers
5.
ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs
1.
RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health
2.
Clinical Pathways in Hematology in Clinical Decision-Making
3.
Immune Surveillance Screening for Early Cancer Risk Detection
4.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
5.
AI-Driven Digital Pathology in Oncology: From Histology Images to Predictive Treatment Biomarkers
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
How Advances in Cancer Research Are Improving Treatment Options
2.
Navigating the Complexities of Ph Negative ALL - Part II
3.
Signs and Symptoms of Leukemia
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation